Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.887
+0.020 (2.29%)
At close: Mar 9, 2026, 4:00 PM EDT
0.891
+0.004 (0.45%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Talphera Revenue
Talphera had revenue of $1,000.00 in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $28.00K, down -90.04% year-over-year.
Revenue (ttm)
$28.00K
Revenue Growth
-90.04%
P/S Ratio
1,444.07
Revenue / Employee
$2,154
Employees
13
Market Cap
41.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Assertio Holdings | 137.35M |
| Rockwell Medical | 75.58M |
| InterCure | 72.16M |
| Aytu BioPharma | 62.64M |
| Cumberland Pharmaceuticals | 41.28M |
| Zhengye Biotechnology Holding | 21.46M |
| SCYNEXIS | 20.60M |
| TherapeuticsMD | 2.80M |
TLPH News
- 7 days ago - Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial - PRNewsWire
- 4 months ago - Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire
- 4 months ago - Talphera Announces the Appointment of Joe Todisco to Board of Directors - PRNewsWire
- 6 months ago - CorMedix Announces Strategic Minority Investment in Talphera - GlobeNewsWire
- 6 months ago - Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market - PRNewsWire
- 7 months ago - Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial - PRNewsWire